Ketryx, the AI-native compliance platform for safety-critical product development, announced the beta launch of its Model Context Protocol server. This development enables AI tools such as ChatGPT, Claude, and Copilot to securely access live compliance data from Ketryx, allowing both people and AI agents to build regulated products with full compliance awareness. The announcement represents a significant step toward integrating artificial intelligence directly into regulated product development workflows, particularly in life sciences where compliance is paramount.
The Model Context Protocol server integrates fragmented product lifecycle management, application lifecycle management, and development tools into a unified knowledge graph. This integration allows teams to use natural-language queries to check compliance status, identify traceability gaps, and verify release readiness without switching between different systems. By creating this unified interface, Ketryx addresses a critical challenge in regulated industries where compliance documentation often exists across disconnected platforms, creating inefficiencies and potential compliance risks.
This development matters because it directly addresses the growing complexity of compliance in safety-critical industries like medical devices and pharmaceuticals. As regulatory requirements become more stringent and product development cycles accelerate, organizations need more efficient ways to maintain compliance throughout the entire product lifecycle. The ability for AI tools to access live compliance data means that developers and compliance teams can get real-time insights without manual data gathering, potentially reducing errors and accelerating time-to-market for critical medical products.
The implications of this announcement extend beyond immediate productivity gains. By enabling AI agents to work with compliance data, Ketryx is creating a foundation for more autonomous compliance management in the future. This could lead to systems that proactively identify compliance issues before they become problems, automatically generate required documentation, and maintain continuous compliance monitoring. For industries where regulatory compliance is non-negotiable, such automation represents both a competitive advantage and a risk mitigation strategy.
The beta launch follows Ketryx's established position in the medical device industry, where it is trusted by four of the world's top five medical device manufacturers. The platform's approach of overlaying existing tools rather than replacing them makes adoption more practical for organizations with established workflows. As AI continues to transform various industries, this development positions Ketryx at the intersection of two critical trends: the increasing use of AI in development workflows and the growing complexity of regulatory compliance in safety-critical sectors. For more information about the company, visit https://www.ketryx.com.
